Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled, Investigator-initiated Human Study to Evaluate the Efficacy and Safety of Lactococcus Lactis KD10 Powder in Improving Autism Spectrum Symptoms in Pediatric Patients With Autism Spectrum Disorder.
NCT06650644 is registered in ClinicalTrials.gov with Miae Oh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-blind, Placebo-controlled, Investigator-initiated Human Study to Evaluate the Efficacy and Safety of Lactococcus Lactis KD10 Powder in Improving Autism Spectrum Symptoms in Pediatric Patients With Autism Spectrum Disorder.
- Lead sponsor
- Miae Oh
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 10, 2024
- Completion date
- July 23, 2025
- Enrollment
- 48 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.